Role of telomerase in the onset and treatment of gastric cancer.
10.11817/j.issn.1672-7347.2025.240400
- Author:
Gang CHEN
1
,
2
,
3
;
Minmin ZHANG
4
;
Yulu WANG
4
;
Yumin LI
1
;
Junmin ZHU
1
,
3
,
5
Author Information
1. Department of General Surgery, Second Hospital, Lanzhou University, Lanzhou
2. chengang201901@
3. com.
4. Second Clinical Medical School, Lanzhou University, Lanzhou 730030, China.
5. zhujm09@
- Publication Type:Review
- Keywords:
autophagic cell death;
autophagy;
gastric cancer;
telomerase;
telomere
- MeSH:
Humans;
Stomach Neoplasms/genetics*;
Telomerase/genetics*;
Autophagy/physiology*
- From:
Journal of Central South University(Medical Sciences)
2025;50(2):259-265
- CountryChina
- Language:English
-
Abstract:
China is a high-incidence region for gastric cancer globally. The disease is characterized by a high morbidity rate, low early diagnostic rate, and poor long-term outcomes, imposing a significant burden on both patients and society. Therefore, exploring the pathogenesis of gastric cancer, developing novel therapeutic strategies, and identifying new drug targets is of great importance. Telomerase expression is broadly associated with cancer cell targeting, and its up-regulation is one of the key factors driving the initiation and progression of gastric cancer. Additionally, telomerase is intricately involved in the regulation of autophagy and autophagy-associated cell death. While autophagy can induce chemoresistance, excessive autophagy may lead to cell death, which also constitutes one of the mechanisms of chemotherapy. Telomerase not only directly contributes to gastric cancer pathogenesis but also indirectly influences its development and treatment by modulating autophagy and autophagic cell death. Therefore, telomerase holds promise as a novel therapeutic target in gastric cancer.
